SCIRP Mobile Website
Paper Submission

Why Us? >>

  • - Open Access
  • - Peer-reviewed
  • - Rapid publication
  • - Lifetime hosting
  • - Free indexing service
  • - Free promotion service
  • - More citations
  • - Search engine friendly

Free SCIRP Newsletters>>

Add your e-mail address to receive free newsletters from SCIRP.

 

Contact Us >>

WhatsApp  +86 18163351462(WhatsApp)
   
Paper Publishing WeChat
Book Publishing WeChat
(or Email:book@scirp.org)

Article citations

More>>

Morgan, J.L., Baggari, S.R., McIntire, D.D. and Sheffield, J.S. (2015) Pregnancy Outcomes after Antepartum Tetanus, Diphtheria, and Acellular Pertussis Vaccination. Obstetrics & Gynecology, 125, 1433-1438.
https://doi.org/10.1097/AOG.0000000000000862

has been cited by the following article:

  • TITLE: Association of Tetanus-Diphtheria Vaccination during Pregnancy with Preeclampsia

    AUTHORS: Kubilay Canga, Pervin Karlı, Ayşe Zehra Özdemir, Mesut Önal, İdris Koçak

    KEYWORDS: Preeclampsia, Tetanus-Diphtheria Vaccination, Vaccination in Pregnancy, Vaccination, Pregnancy

    JOURNAL NAME: Open Journal of Obstetrics and Gynecology, Vol.8 No.12, October 12, 2018

    ABSTRACT: Introduction: The tetanus-diphtheria vaccine administered during pregnancy is used as a toxoid vaccine with an intact antigen structure. In this study, we investigated the association of tetanus-diphtheria vaccination (TDV) during pregnancy with adverse maternal and neonatal outcomes and particularly preeclampsia that may occur during pregnancy. Materials and Methods: From the patients who presented to our clinic between 01.01.2016 and 31.12.2016 and underwent a cesarean section, a total of 435 patients, 327 who received TDV and 108 who did not receive TDV, were included in the study. The groups were compared with respect to their demographic characteristics. The patient data on the gestational week, birth weight, normal newborn, preeclampsia, small for gestational age (SGA), early membrane rupture, preterm labor, diabetic mother’s baby, prematurity, temporary neonatal tachypnea, newborn’s need for intensive care, and neonatal mortality were recorded. Results: While 14.7% of the women who had been administered TDV had preeclampsia diagnosis during their pregnancy, 12% of those who had not been vaccinated were diagnosed with preeclampsia. This showed no significant correlation between having been vaccinated during pregnancy and preeclampsia (p = 0.474). The other outcomes we had specified had also no statistically significant correlations with vaccination during pregnancy. Having been vaccinated during pregnancy was found correlated only with the place of residence and nulliparity (p = 0.004 and p = 0.002, respectively). Conclusion: No correlation was found in the study between TDV during pregnancy and preeclampsia. According to the data obtained from this study, vaccination was found to have no negative effect on preeclampsia or the other outcomes.